Skip to main content

Advertisement

SpringerLink
Log in

Recent advances in temporal arteritis

  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

Temporal arteritis was first described in the late nineteenth century. Despite considerable progress in understanding the disease, its rarity in the young and in those who are not of Scandinavian ethnicity remains unexplained. Microbiologic agents and immunologic mechanisms have been implicated as causative factors. Although steroids remain the drug of choice, the use of other immunologic therapies has been proposed. This paper reviews the disease’s history, probable etiologies, clinical manifestations, and its diagnostic and treatment challenges.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Hutchinson J: Disease of the arteries. Arch Surg 1889, 1:323–329.

    Google Scholar 

  2. Horton BT, Magath TB, Brown GE: An undescribed form of arteritis of the temporal vessels. Proc Mayo Clin 1932, 7:700–701.

    Google Scholar 

  3. Horton BT, Magath TB: Arteritis of the temporal vessels: report of seven cases. Proc Mayo Clin 1937, 12:548–553.

    Google Scholar 

  4. Gilmore JR: Giant cell arteritis. J Pathol Bacteriol 1941, 53:263–277.

    Article  Google Scholar 

  5. Paulley JW, Hughes JP: Giant cell arteritis or arteritis of the aged. BMJ 1960, 2:1562–1567.

    PubMed  CAS  Google Scholar 

  6. Rajala SA, Ahvenainen JE, Mattila KJ, Saarni MI: Incidence and survival rate in cases of biopsy-proven temporal arteritis. Scand J Rheumatol 1993, 22:289–291.

    PubMed  CAS  Google Scholar 

  7. Tore JG: Some thoughts about the etiopathogenesis of temporal arteritis: a review. Scand J Rheumatol 2002, 31:1–5.

    Google Scholar 

  8. Huston K, Hunder G, Lie JT, et al.: Temporal arteritis: a 25-year epidemiologic, clinical and pathologic study. Ann Int Med 1978, 88:162–167.

    PubMed  CAS  Google Scholar 

  9. Gonzalez-Gay M, Garcia-Porrua C, Llorca J, et al.: Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for temporal artery biopsy. Semin Arthritis Rheum 2001, 30:249–256.

    Article  PubMed  CAS  Google Scholar 

  10. Franchesi M, Colombo B, Rossi P, Canal N: Headache in a population-based elderly cohort: an ancillary study to the Italian Longitudinal Study of Aging (ILSA). Headache 1997, 37:79–82.

    Article  Google Scholar 

  11. Gur H, Rapman E, Ehrenfeld M, Sidi Y: Clinical manisfestations of temporal arteritis: a report from Israel. J Rheumatol 1996, 23:1927–1931.

    PubMed  CAS  Google Scholar 

  12. Nir-Paz R, Gross A, Chajek-Shaul T: Reduction of jaw opening (trismus) in giant cell arteritis. Ann Rheum Dis 2002, 61:832–833.

    Article  PubMed  CAS  Google Scholar 

  13. Procter CD, Hollier LH, Trosclair C: Temporal arteritis: clinical implications for the vascular surgeon. J Cardiovasc Surg 1992, 33:599–603.

    Google Scholar 

  14. O’Brien JP, Regan W: Is damage by the sun and other actinic radiation the basis for temporal arteritis [letter]? Med J Aust 1992, 156:580.

    PubMed  CAS  Google Scholar 

  15. Duhaut P, Pinede L, Demolombe-Rague S, et al.: Giant cell arteritis and cardiovascular risk factors: a multicenter, prospective case-control study. Arthritis Rheum 1998, 41:1960–1965.

    Article  PubMed  CAS  Google Scholar 

  16. Mitchell BM, Font RL: Detection of varicella zoster virus DNA in some patients with giant cell arteritis. Invest Ophthalmol Vis Sci 2001, 42:2572–2577.

    PubMed  CAS  Google Scholar 

  17. Rimenti G, Blasi F, Cosentini R, et al.: Temporal arteritis associated with Chlamydia pneumoniae DNA detected in an artery specimen. J Rheumatol 2000, 27:2718–2720.

    PubMed  CAS  Google Scholar 

  18. Haugeberg G, Bie R, Nordbo SA: Temporal arteritis associated with Chlamydia pneumoniae DNA detected in an artery specimen [letter]. J Rheumatol 2001, 28:7–8.

    Google Scholar 

  19. Regan MJ, Wood BJ, Hsieh YH, et al.: Chlamydia penumoniae and temporal arteritis: no association by polymerase chain reaction (PCR) analyses of temporal artery biopsies. Arthritis Rheum 2001, 44(suppl):S391.

    Google Scholar 

  20. Helweg-Larsen J, Tarp B, Obel N, Baslund B: No evidence of parvovirus B19, Chlamydia pneumoniae or human herpes virus infection in temporal artery biopsies in patients with giant cell arteritis. Rheumatology 2002, 41:445–449. This prospective study shows a negative association of temporal arteritis with parvovirus, Chlamydia, and human herpes virus.

    Article  PubMed  CAS  Google Scholar 

  21. Schoen EJ: Temporal arteritis after Hymenoptera sting [letter]. J Rheumatol 1998, 25:2040–2042.

    PubMed  CAS  Google Scholar 

  22. Finsterer J, Artner C, Kladosek A, et al.: Cavernous sinus syndrome due to vaccination-induced giant cell arteritis. Arch Int Med 2001, 161:1008–1009.

    Article  CAS  Google Scholar 

  23. Brack A, Martinez-Taboada V, Stanson A, et al.: Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 1999, 42:311–317.

    Article  PubMed  CAS  Google Scholar 

  24. Poller DN, van Wyk Q, Jeffrey MJ: The importance of skip lesions in temporal arteritis. J Clin Pathol 2000, 53:137–139.

    Article  PubMed  CAS  Google Scholar 

  25. Solomon S, Guglielmo Cappa K: The headache of temporal arteritis. J Am Geriatr Soc 1987, 35:163–165.

    PubMed  CAS  Google Scholar 

  26. Jimenez-Jimenez FJ, Garcia-Albea E, Zurdo M, et al.: Giant cell arteritis presenting as cluster headache. Neurology 1998, 51:1767–1768.

    PubMed  CAS  Google Scholar 

  27. Jundt JW, Mock D: Temporal arteritis with normal erythrocyte sedimentation rate presenting as occipital neuralgia. Arthritis Rheum 1991, 34:217–219.

    Article  PubMed  CAS  Google Scholar 

  28. Salvarani C, Gabriel SE, O’Fallon WM, Hunder GG: Epidemiology of polymyalgia rheumatica in Olmstead County, Minnesotta, 1970–1991. Arthritis Rheum 1995, 38:369–373.

    Article  PubMed  CAS  Google Scholar 

  29. Narvaez J, Nolla-Sole JM, Narvaez JA, et al.: Musculoskeletal manifestations in polmyalgia rheumatica and temporal arteritis. Ann Rheum Dis 2001, 60:1060–1063.

    Article  PubMed  CAS  Google Scholar 

  30. Gran JT, Myklebust G, Wilsgaard T, Jacobsen BK: Survival in polymyalgia rheumatica and temporal arteritis: a study of 398 cases and matched population controls. Rheumatology 2001, 40:1238–1242. Comparison of mortality rates among patients with temporal arteritis and polymyalgia rheumatica and control subjects.

    Article  PubMed  CAS  Google Scholar 

  31. Liozon E, Herrmann F, Ly K, et al.: Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients. Am J Med 2001, 111:211–217. Estimates the prevalence of visual loss in temporal arteritis and associated risk factors.

    Article  PubMed  CAS  Google Scholar 

  32. Font C, Cid MC, Coll-Vincent B, et al.: Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis. Br J Rheumatol 1997, 36:251–254.

    Article  PubMed  CAS  Google Scholar 

  33. Nescher G, Nescher R, Rozenman Y, Sonnenblick M: Visual hallucinations in giant cell arteritis: association with visual loss. J Rheumatol 2001, 28:2046–2048.

    Google Scholar 

  34. Schmidt D, Vaith P, Hetzel A: Prevention of serious ophthalmic and cerebral complications in temporal arteritis. Clin Exp Rheumatol 2000, 18(suppl 20):S61-S63.

    PubMed  CAS  Google Scholar 

  35. Gonzalez-Gay M, Blanco R, Rodriguez-Valverde V, et al.: Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment. Arthritis Rheum 1998, 41:1497–1504.

    Article  PubMed  CAS  Google Scholar 

  36. Hellman D: Temporal arteritis: a cough, toothache and tongue infarction. JAMA 2002, 287:2996–3000.

    Article  Google Scholar 

  37. Butler JV, Callaghan J, O’Keffe S, Mulkerrin EC: Giant cell arteritis and pericardial effusion. Ir Med J 2001, 94:87–88.

    PubMed  CAS  Google Scholar 

  38. Garcia-Alfranca F, Solans R, Simeon C, et al.: Pleural effusion as a form of presentation of temporal arteritis [letter]. Br J Rheumatol 1998, 37:802–803.

    Article  PubMed  CAS  Google Scholar 

  39. Perez-Vega C, Narvaez J, Vilaseca J: Giant cell arteritis presenting as transient vertebrobasilar ischemic attacks. Am J Med 2001, 111:578–579.

    Article  PubMed  CAS  Google Scholar 

  40. Galetta SL, Balcer LJ, Lieberman AP, et al.: Refractory giant cell arteritis with spinal cord infarction. Neurology 1997, 49:1720–1723.

    PubMed  CAS  Google Scholar 

  41. Sendino A, Barbado FJ, Gonzalez-Anglada I, et al.: Temporal arteritis: a form of systemic panarteritis. Ann Rheum Dis 1992, 51:1082–1084.

    PubMed  CAS  Google Scholar 

  42. Phelan MJ, Kok K, Burrow C, Thompson RN: Small bowel infarction in association with giant cell arteritis. Br J Rheumatol 1993, 32:63–65.

    Article  PubMed  CAS  Google Scholar 

  43. Gekas G, Spengos K: Scalp necrosis: a rare complication of temporal arteritis. Cerebrovasc Dis 2002, 13:146.

    Article  PubMed  CAS  Google Scholar 

  44. Marcos O, Cebrecos AI, Prieto A, Sancho de Salas M: Tongue necrosis in a patient with temporal arteritis. J Oral Maxillofac Surg 1998, 56:1203–1206.

    Article  PubMed  CAS  Google Scholar 

  45. Cikes A, Depairon M, Jolidon RM, et al.: Necrosis of the tongue and unilateral blindness in temporal arteritis. Vasa 2001, 30:222–224.

    Article  PubMed  CAS  Google Scholar 

  46. Ganiats TG: Temporal arteritis with normal erythrocyte sedimentation rate. J Am Board Fam Practice 1991, 4:119–122.

    CAS  Google Scholar 

  47. Wise CM, Agudelo CA, Chmelewski WL, McKnight KM: Temporal arteritis with low erythrocyte sedimentation rate: a review of five cases. Arthritis Rheum 1991, 34:1571–1574.

    Article  PubMed  CAS  Google Scholar 

  48. Lincoff S, Erlich PD, Brass LS: Thrombocytosis in temporal arteritis: rising platelet counts: a red flag for giant cell arteritis. J Neuroophthal 2000, 20:67–72.

    CAS  Google Scholar 

  49. Eshagian J, Goeken JA: C-reactive protein in giant cell (cranial, temporal) arteritis. Ophthalmol 1980, 87:160.

    Google Scholar 

  50. Hayreh SS, Podhajsky PA, Raman R, et al.: Giant cell arteritis: validity and reliability of various diagnostic data. Am J Ophthalmol 1997, 123:285–296.

    PubMed  CAS  Google Scholar 

  51. Cid MC, Monteagudo J, Oristrell J, et al.: Von Willebrand factor in the outcome of temporal arteritis. Ann Rheum Dis 1996, 55:927–930.

    Article  PubMed  CAS  Google Scholar 

  52. Weyand CM, Fulbright JW, Hunder GG, et al.: Treatment of giant cell arteritis: interleukin-6 as a biologic marker for disease activity. Arthritis Rheum 2000, 43:1041–1048.

    Article  PubMed  CAS  Google Scholar 

  53. Duhaut P, Berruyer M, Pinede L, et al.: Anticardiolipin antibodies and giant cell arteritis: a prospective multicenter casecontrol study. Arthritis Rheum 1998, 41:701–709.

    Article  PubMed  CAS  Google Scholar 

  54. Mohamed MS, Bates T: Predictive clinical and laboratory factors in the diagnosis of temporal arteritis. Ann R Coll Surg Eng 2002, 84:7–9.

    CAS  Google Scholar 

  55. Salvarani C, Silingardi M, Ghirarduzzi A, et al.: Is duplex ultrasonography useful for the diagnosis of giant-cell arteritis? Ann Int Med 2002, 137:E232-E238. The authors describe the use of duplex ultrasonography as a diagnostic tool in temporal arteritis.

    Google Scholar 

  56. Danish-Meyer H, Savino PJ, Eagle RC Jr, et al.: Low diagnostic yield with second biopsies in suspected giant cell arteritis. J Neuroophthal 2000, 20:213–215.

    Google Scholar 

  57. Pless M, Rizzo JF, Lamkin JC, Lessell S: Concordance of bilateral temporal artery biopsy in giant cell arteritis. J Neuroophthalmol 2000, 20:216–218.

    PubMed  CAS  Google Scholar 

  58. Ray-Chadhuri N, Kine DA, Tijani SO, et al.: Effect of prior steroid treatment on temporal artery biopsy findings in giant cell arteritis. Br J Ophthal 2002, 86:530–532. This study shows that most temporal artery biopsies may still be positive even 4 weeks after the initiation of steroid therapy.

    Article  Google Scholar 

  59. Evans JM, Batts KP, Hunder GG: Persistent giant cell arteritis despite corticosteroid treatment. Mayo Clin Proc 1994, 69:1060–1061.

    PubMed  CAS  Google Scholar 

  60. Murgatroyd H, Milne A: Positive temporal artery biopsy in a patient on therapeutic doses of steroids for six years. Eye 2001, 15(Pt 2):250–251.

    PubMed  CAS  Google Scholar 

  61. Lie JT: Temporal artery biopsy diagnosis of giant cell arteritis: lessons from 1109 biopsies. Anat Pathol 1996, 1:69–97.

    PubMed  CAS  Google Scholar 

  62. Schmidt WA, Kraft HE, Vorpahl K, et al.: Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 1997, 337:1336–1342.

    Article  PubMed  CAS  Google Scholar 

  63. Lauwerys BR, Puttemans T, Houssiau FA, Devogelaer JP: Color Doppler Sonography of the temporal arteries in giant cell arteritis and polymyalgia rheumatica. J Rheumatol 1997, 24:1570–1574.

    PubMed  CAS  Google Scholar 

  64. Lopez JM, Nazabal ER, Muniz AM, Rey del Corral P: Detection of posterior ischemic optic neuropathy due to giant cell arteritis with magnetic resonance imaging. Eur Neurol 2001, 46:109–110.

    Article  PubMed  CAS  Google Scholar 

  65. Joelson E, Ruthrauff B, Ali F, et al.: Multifocal dural enhancement associated with temporal arteritis. Arch Neurol 2000, 57:119–122.

    Article  PubMed  CAS  Google Scholar 

  66. Anders HJ, Sigl T, Sander A, et al.: Gadolinium contrast magnetic resonance imaging of the temporal artery in giant cell arteritis [letter]. J Rheumatol 1999, 26:2288–2239.

    Google Scholar 

  67. Mitomo T, Funyu T, Takahashi Y, et al.: Giant cell arteritis and magnetic resonance angiography. Arthritis Rheum 1998, 41:1702.

    Article  PubMed  CAS  Google Scholar 

  68. Nescher G, Rubinow A, Sonnenblick M: Efficacy and adverse effects of different corticosteroid dose regimens in temporal arteritis. Clin Exp Rheumatol 1997, 15:303–306.

    Google Scholar 

  69. Myklebust G, Gran JT: Prednisolone maintenance dose in relation to starting dose in the treatment of polymyalgia rheumatica and temporal arteritis. Scand J Rheumatol 2001, 30:260–267.

    Article  PubMed  CAS  Google Scholar 

  70. Kupersmith MJ, Langer R, Mitnick H, et al.: Visual performance in giant cell arteritis (temporal arteritis) after 1 year of therapy. Br J Ophthal 1999, 83:796–801.

    Article  CAS  Google Scholar 

  71. Hernandez-Rodriguez J, Garcia-Martinez A, Casademont J, et al.: A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration therapy in patients with giant cell arteritis. Arthritis Rheum 2002, 47:29–35.

    Article  PubMed  CAS  Google Scholar 

  72. Cacoub P, Chemlal K, Khalifa P, et al.: Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss. J Rheumatol 2001, 28:2474–2478.

    PubMed  CAS  Google Scholar 

  73. Liozon F, Vidal E, Barrier J: Does dapsone have a role in the treatment of temporal arteritis with regard to efficacy and toxicity [letter]? Clin Exp Rheumatol 1993, 11:694–695.

    PubMed  CAS  Google Scholar 

  74. Nesher G, Sonnenblick M: Steroid-sparing medications in temporal arteritis: report of three cases and review of 174 reported patients. Clin Rheumatol 1994, 13:289–292.

    PubMed  CAS  Google Scholar 

  75. Spiera RF, Mitnick HJ, Kupersmith M, et al.: A prospective, double-blind randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA). Clin Exp Rheumatol 2001, 19:495–501.

    PubMed  CAS  Google Scholar 

  76. Jover JA, Hernandez-Garcia C, Morado IC, et al.: Combined treatment of giant cell arteritis with methotrexate and prednisone: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2001, 134:106–114.

    PubMed  CAS  Google Scholar 

  77. Cantini F, Niccoli L, Salvarani C, et al.: Treatment of longstanding giant cell arteritis with infliximab: report of four cases. Arthritis Rheum 2001, 44:2933–2935. Infliximab may be a promising alternative to steroids in the treatment of temporal arteritis. Unlike steroids, infliximab was not associated with any adverse effects and was well tolerated.

    Article  PubMed  CAS  Google Scholar 

  78. Kupersmith MJ, Spiera R, Langer R, et al.: Visual function and quality of life among patients with giant cell (temporal) arteritis. J Neuroophthal 2001, 21:266–273. A quality of life study among temporal arteritis patients with and without visual loss. The Activities of Daily Vision Scale and Short Form of Health Survey revealed that only the day-driving score was affected.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Marshfield Clinic, 1000 N. Oak Avenue, 54449, Marshfield, WI, USA

    Carol Redillas MD

  2. Headache Unit, Montefiore Medical Center, Albert Einstein College of Medicine, 111 E. 210th Street, 10467, Bronx, NY, USA

    Seymour Solomon MD

Authors
  1. Carol Redillas MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Seymour Solomon MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Redillas, C., Solomon, S. Recent advances in temporal arteritis. Current Science Inc 7, 297–302 (2003). https://doi.org/10.1007/s11916-003-0050-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11916-003-0050-0

Keywords

Search

Navigation